Accent Microcell (NSE:ACCENTMIC) Marketable Securities: ₹106 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACCENTMIC Accent Microcell Ltd NSE:ACCENTMIC
47 GF Score
Price ₹605.85
! 6 Warning Signs
View Full Analysis

What is Accent Microcell Marketable Securities?

Accent Microcell NSE:ACCENTMIC +2.32% 47 Marketable Securities is ₹106 Mil as of Mar. 2026. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 47/100. The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Accent Microcell's Marketable Securities for the quarter that ended in Mar. 2026 was ₹106 Mil.

Accent Microcell's annual Marketable Securities declined from Mar. 2024 (₹708 Mil) to Mar. 2025 (₹471 Mil) and declined from Mar. 2025 (₹471 Mil) to Mar. 2026 (₹106 Mil).


Accent Microcell  (NSE:ACCENTMIC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Accent Microcell Marketable Securities Related Terms


Accent Microcell Marketable Securities Historical Data

* Premium members only.

The historical data trend for Accent Microcell's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell Marketable Securities Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 17.26 17.36 707.69 470.76 106.47

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities Get a 7-Day Free Trial 17.26 17.36 707.69 470.76 106.47
NSE:ACCENTMIC
47GF Score
Accent Microcell Ltd NSE:ACCENTMIC
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accent Microcell Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹106 Mil mean?
Accent Microcell (NSE:ACCENTMIC) has a Marketable Securities of ₹106 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Accent Microcell and its competitors.
Is Accent Microcell's Marketable Securities too high?
Accent Microcell's current Marketable Securities is ₹106 Mil. Overall, Accent Microcell has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Marketable Securities compare to ZTS?
Accent Microcell's Marketable Securities of ₹106 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Accent Microcell and its competitors. Accent Microcell's current Marketable Securities is ₹106 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Marketable Securities of ₹106 Mil. The current Marketable Securities is ₹106 Mil. Accent Microcell's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Marketable Securities is ₹106 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accent Microcell Business Description

Address Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
47GF Score

Get the complete analysis for NSE:ACCENTMIC

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹605.85
Price